ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME questions
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Pantosti, A.
Right arrow Articles by Venditti, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pantosti, A.
Right arrow Articles by Venditti, M.
Eur Respir J 2009; 34:1190-1196
Copyright ©ERS Journals Ltd 2009

What is MRSA?

A. Pantosti1 and M. Venditti2

1 Dept of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, and 2 Dept of Infectious Diseases, Policlinico Umberto I, University of Rome "Sapienza", Rome, Italy.

CORRESPONDENCE: A. Pantosti, Dept of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, 00161, Italy. E-mail: annalisa.pantosti{at}iss.it

Keywords: Antibiotic resistance, community-acquired pneumonia, methicillin-resistant Staphylococcus aureus, necrotising pneumonia, nosocomial pneumonia, Staphylococcus aureus

Received: January 16, 2009
Accepted June 5, 2009

For decades methicillin-resistant Staphylococcus aureus (MRSA) has been considered the prototype of multi-resistant nosocomial pathogens, causing infections in high-risk patients. Changes in the healthcare system, coupled with the evolution of this versatile microorganism, have transformed MRSA into a cause of community-onset infections, in both patients who have contact with the healthcare system and patients without such a risk factor.

New lineages of MRSA, defined as community acquired (CA)-MRSA, have emerged that have a propensity to cause infections in young individuals without risk factors. CA-MRSA primarily causes skin infections and, rarely, necrotising pneumonia. In the USA, these strains belong to a single widespread clone, designated USA300, while in Europe they belong to a variety of clones. Most strains carry genes for the Panton–Valentine leukocidin, whose role in diseases is under debate.

In subjects living in the community who have contact with the healthcare system, MRSA strains of the nosocomial type are a frequent cause of infection and of pneumonia in particular. The detection of a large MRSA reservoir in pigs and the finding that professionally exposed individuals are colonised, has further shown that it is necessary to closely follow the epidemiology of MRSA if we want to combat it effectively.




This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Nakou, M. Woodhead, and A. Torres
MRSA as a cause of community-acquired pneumonia
Eur. Respir. J., November 1, 2009; 34(5): 1013 - 1014.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.